Delegation Led by Chen Qiquan, Vice Director of Hangzhou Municipal Committee of Civil Military Integration Development Office, Visited Sumgen Biotech

date:2019-11-07      source:


On the morning of Nov. 6, 2019, Chen Qiquan, Vice Director of Hangzhou Municipal Committee of Civil Military Integration Development Office, and his delegation visited Sumgen Biotech for a special research on the military-civilian integrated innovative development of biomedicine. This delegation also included representatives from the Binjiang District Development and Reform Bureau and People's Armed Forces Department.

Dr. Tan Bin, Vice President of Sumgen Biotech, presented the Company's overall development, technical advantages in R&D, layout of pipelines under research, and future development goals to the special research team, and had in-depth discussions with the research team on the Company's main practices of military-civilian integration and plan for future development under the current trends. Director Chen highly appraised Sumgen Biotech for its implementation of national strategies and active participation in military scientific research and technical research, and supported the Company’s overall plan for the construction of industrialized bases and active participation in national and military strategic R&D and production tasks. Director Chen pointed out that biomedicine has strong military-civilian versatility. Military-civilian integrated innovative development of biomedicine is a specific measure of the national military-civilian integration strategy implemented by our city, and Sumgen Biotech has extensive experience and practice in this process. Director Chen hoped that local government departments can increase their support and improve matching policies to guide and encourage more companies to participate in the practice of military-civilian integration and make positive contributions to the development of military-civilian integration in Hangzhou.


Copyright Rm. 301, F3, Building C, Block 2, No. 688, Bin'an Road, Changhe Zhejiang ICP Filing No. 18039044